Transcultural Validation of the French Version of the " Patients' Endorsement of a Biopsychosocial Model of Chronic Pain " Scale
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Pain, Chronic
- Sponsor
- Benno Rehberg-Klug
- Enrollment
- 80
- Locations
- 1
- Primary Endpoint
- incremental validity of the new ABDC scale
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
We will validate the French version of the "Patients' Endorsement of a Biopsychosocial model of chronic pain (PEB) scale" by comparing it to the "pain self-efficacy" questionnaire
Detailed Description
The primary objective is to validate the French version of the PEB scale, called "Echelle d'Adhésion du modèle Bio-psycho-social par des patients avec Douleur Chronique ABDC". The hypothesis is that the ABDC scale is a valid measurement tool to measure and operationalize beliefs about the biopsychosocial nature of pain in adults with chronic pain. Consenting patients will receive paper copies of the study questionnaire including the questionnaires named in the secondary outcomes section, except those which are already included in the standard evaluation questionnaire of the pain consultation (BPI, GAD-7, PHQ-9). Patients will return the questionnaire either at a the same or a follow-up consultation, or send in the questionnaire by post in a prepaid envelope.
Investigators
Benno Rehberg-Klug
Clinical professor
University Hospital, Geneva
Eligibility Criteria
Inclusion Criteria
- •- Patients with chronic pain (defined by ICD-11 as pain persisting or recurring longer than 3 months) having a chronic pain consultation at the HUG
- •French-speaking and able to understand the study information
- •≥18 years of age
Exclusion Criteria
- •- Inability to understand the consent form and the questionnaire, e.g. due to lan-guage problems, psychological disorders, dementia, etc. of the participant
- •Enrolment of the investigator, his/her family members, employees and other de-pendent persons
Outcomes
Primary Outcomes
incremental validity of the new ABDC scale
Time Frame: 1 day
Incremental validity is the degree to which a new scale increases the ability to predict an outcome beyond existing parameters and scales. In our case pain self-efficacy, measured by the "pain self-efficacy questionnaire" \[8\], which exists in a validated French version \[9\], is the outcome to be predicted. Hierarchical regression analysis will have four models including in hierarchical order 8 explanatory variables: demographical variables (gender, age, level of education), depressive symptoms and anxiety, pain catastrophizing, pain acceptance, and finally the ABDC scale
Secondary Outcomes
- Reliability of the ABDC scale(1 day)
- Convergent validity(1 day)
- Discriminant validity(1 day)